Double-Blind Naltrexone in Kleptomania
NCT00332579 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2019-07-29
Summary
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in kleptomania.
Conditions
- Kleptomania
Interventions
- DRUG
-
Naltrexone
daily
- DRUG
-
daily
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jon E Grant, MD, JD · University of Minnesota
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-01
- Primary Completion
- 2008-09-01
- Completion
- 2008-09-01
Countries
- United States
Study Locations
More Related Trials
-
Influence of Medication on Functional Connectivity
NCT03612713 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT03773523 ·Status: RECRUITING ·Phase: NA
-
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
NCT03679949 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients
NCT03369639 ·Status: WITHDRAWN
-
Propranolol Versus Propranolol and Clonidine in Sympathetic Hyperactivity After Moderate Traumatic Brain Injury
NCT04833218 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II
NCT02652195 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants
NCT03808259 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity
NCT00205946 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine Dependents
NCT03748875 ·Status: UNKNOWN ·Phase: NA
-
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
NCT04178993 ·Status: COMPLETED ·Phase: PHASE1
-
Inhibitory Control: Effects of Modulation
NCT04247334 ·Status: RECRUITING ·Phase: NA
-
Endogenous Opioid Modulation by Ketamine
NCT03051945 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942 ·Status: TERMINATED ·Phase: PHASE1
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
The Effects of ∆-9-THC and Naloxone in Humans
NCT01591629 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Citicholine-Amantadine Trial in Traumatic Brain Injury
NCT03430817 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Fentanyl Abuse on Executive Function and Related Brain Activity
NCT05469217 ·Status: UNKNOWN
-
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394 ·Status: SUSPENDED ·Phase: PHASE3
-
Prevalence, Awareness, Attitudes and Patterns of Stimulant Drug Use Among Students in Egyptian Universities
NCT06646822 ·Status: ACTIVE_NOT_RECRUITING
-
Ketamine IV Classic Protocol : Five Years Follow up
NCT04824157 ·Status: COMPLETED
-
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
NCT00916253 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Cognitive Enhancement
NCT01684306 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
tDCS to Decrease Opioid Relapse (UG3)
NCT03842137 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
NCT01755091 ·Status: COMPLETED ·Phase: PHASE2
-
N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms
NCT03221231 ·Status: UNKNOWN ·Phase: PHASE4